首页 | 本学科首页   官方微博 | 高级检索  
检索        

CT引导下125I放射性粒子植入治疗原发性肝细胞癌伴门静脉癌栓
引用本文:林俊清,杨维竹,江娜,郑曲彬,黄兢姚,黄宁.CT引导下125I放射性粒子植入治疗原发性肝细胞癌伴门静脉癌栓[J].中国介入影像与治疗学,2011,8(4):299-302.
作者姓名:林俊清  杨维竹  江娜  郑曲彬  黄兢姚  黄宁
作者单位:福建医科大学附属协和医院介入科,福建,福州,350001
摘    要:目的探讨CT引导下125I放射性粒子植入术治疗原发性肝细胞癌(HCC)合并门静脉癌栓(PVTT)的疗效。方法根据放射性粒子植入计划系统(TPS系统),通过CT引导对47例HCC合并PVTT患者于TACE后植入^125I放射性粒子,癌栓处方剂量100~120 Gy,对比治疗前后癌栓长径、肝功能、AFP的变化。结果完全缓解无,部分缓解29例,总有效率为61.70%(29/47);术后癌栓长径明显小于术前(P〈0.05)。接受^125I放射性粒子植入治疗后,47例患者1年、2年生存率分别为53.45%、36.75%,平均生存期为(14±2)个月。结论 CT引导下125I放射性粒子植入术治疗HCC伴PVTT可明显提高疗效,创伤小、恢复快、并发症少。

关 键 词:  肝细胞  门静脉  碘同位素
收稿时间:1/6/2011 12:00:00 AM
修稿时间:2011/2/10 0:00:00

CT-guided iodine-125 seed implantation in the treatment of primary hepatocellular carcinoma combined with portal vein tumor thrombus
LIN Jun-qing,YANG Wei-zhu,JIANG N,ZHENG Qu-bin,HUANG Jing-yao and HUANG Ning.CT-guided iodine-125 seed implantation in the treatment of primary hepatocellular carcinoma combined with portal vein tumor thrombus[J].Chinese Journal of Interventional Imaging and Therapy,2011,8(4):299-302.
Authors:LIN Jun-qing  YANG Wei-zhu  JIANG N  ZHENG Qu-bin  HUANG Jing-yao and HUANG Ning
Institution:Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou 350001, China;Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou 350001, China;Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou 350001, China;Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou 350001, China;Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou 350001, China;Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou 350001, China
Abstract:
Keywords:Carcinoma  hepatocellular  Portal vein  Iodine isotopes
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国介入影像与治疗学》浏览原始摘要信息
点击此处可从《中国介入影像与治疗学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号